P Mahoney Selected Research

Postmenopausal Osteoporosis

5/2004	Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
5/2004	Efficacy and safety of ibandronate given by intravenous injection once every 3 months.
3/2004	Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.
10/2003	Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.
4/2003	The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Mahoney Research Topics

Disease

5	Postmenopausal Osteoporosis 05/2004 - 04/2003
4	Wounds and Injuries (Trauma) 04/2023 - 01/2008
2	Multiple Trauma (Multiple Injuries) 12/2010 - 05/2009
2	Bone Resorption 05/2004 - 05/2004
1	Penetrating Head Injuries (Penetrating Head Injury) 04/2023
1	Accidental Injuries 10/2020
1	Infections 10/2020
1	Traumatic Amputation (Traumatic Amputations) 07/2018
1	Lung Injury 03/2017
1	Abdominal Aortic Aneurysm 05/2009
1	Brain Injuries (Brain Injury) 05/2009
1	Septic Shock (Toxic Shock Syndrome) 05/2009
1	Acromegaly 09/2007
1	Hip Fractures (Intertrochanteric Fractures) 05/2004
1	Metabolic Bone Diseases (Osteopenia) 10/2003
1	Osteoporosis 04/2003
1	Syncope (Fainting) 03/2000

Drug/Important Bio-Agent (IBA)

5	Ibandronic Acid (Boniva)FDA Link 05/2004 - 04/2003
4	Diphosphonates (Bisphosphonates)IBA 05/2004 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 05/2004 - 03/2004
1	Explosive Agents (Explosives)IBA 07/2018
1	S-(1-phenyl-2-hydroxyethyl)cysteine (PHEC)IBA 08/2017
1	Ketamine FDA LinkGeneric 05/2009
1	Insulin-Like PeptidesIBA 09/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2007
1	Growth Hormone (Somatotropin)IBA 09/2007
1	MineralsIBA 05/2004
1	CalciumIBA 03/2000

Therapy/Procedure

4	Therapeutics 03/2017 - 05/2004
2	Resuscitation 06/2009 - 05/2009
2	Injections 05/2004 - 05/2004
1	Surgical Amputation (Amputations) 04/2023
1	Analgesia 10/2020
1	Critical Care (Surgical Intensive Care) 12/2010
1	Surgical Instruments (Clip) 01/2008
1	Fracture Fixation 05/2004